Advocacy intelligence hub — real-time data for patient organizations
Massachusetts Eye and Ear Infirmary — PHASE1
Chengdu Kangnuoxing Biopharma,Inc. — PHASE3
Centre Hospitalier Universitaire de Nice
University Hospital, Rouen
CHU de Reims — NA
Centre hospitalier de l'Université de Montréal (CHUM)
University Hospital, Rouen — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Dupixent
Regeneron Pharmaceuticals, Inc.
Pascal JOLY, Pr
University Hospital, Rouen
Aaron Mangold, MD, M.D
Mayo Clinic
📍 SCOTTSDALE, AZ
Passeron Thierry, PhD
CHU de Nice, Dermatologie
Alessandro Villa, DDS, PhD, MPH
University of California, San Francisco
Stefan Beissert, MD
Dermatology, Univ. of Muenster, Germany
Dagmar Simon
Inselspital, Bern University Hospital